Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:CNC
CUSIP15135B10
Phone314-725-4477
Debt
Debt-to-Equity Ratio0.68
Current Ratio1.01
Quick Ratio1.01
Price-To-Earnings
Trailing P/E Ratio26.93
Forward P/E Ratio19.21
P/E Growth1.3
Sales & Book Value
Annual Sales$48.38 billion
Price / Sales0.57
Cash Flow$7.2433 per share
Price / Cash18.70
Book Value$39.78 per share
Price / Book3.40
Profitability
EPS (Most Recent Fiscal Year)$5.03
Net Income$828 million
Net Margins2.06%
Return on Equity15.69%
Return on Assets4.75%
Miscellaneous
Employees33,700
Outstanding Shares205,180,000
Market Cap$27,791.47
Centene (NYSE:CNC) Frequently Asked Questions
What is Centene's stock symbol?
Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
How were Centene's earnings last quarter?
Centene Corp (NYSE:CNC) released its earnings results on Tuesday, April, 24th. The company reported $2.17 EPS for the quarter, topping analysts' consensus estimates of $1.92 by $0.25. The firm earned $13.19 billion during the quarter, compared to analyst estimates of $13.33 billion. Centene had a net margin of 2.06% and a return on equity of 15.69%. The business's quarterly revenue was up 12.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.12 EPS. View Centene's Earnings History.
When is Centene's next earnings date?
What guidance has Centene issued on next quarter's earnings?
Centene issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $6.75-7.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.16. The company issued revenue guidance of $58.2-59.0 billion, compared to the consensus revenue estimate of $60.55 billion.
What price target have analysts set for CNC?
15 analysts have issued 12 month price objectives for Centene's shares. Their predictions range from $95.00 to $150.00. On average, they expect Centene's share price to reach $129.2857 in the next year. This suggests that the stock has a possible downside of 4.6%. View Analyst Ratings for Centene.
What is the consensus analysts' recommendation for Centene?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
What are Wall Street analysts saying about Centene stock?
Here are some recent quotes from research analysts about Centene stock:
- 1. According to Zacks Investment Research, "In a year's time, Centene's shares have outperformed the industry. The company’s strong and consistent performance is likely to have generated confidence among investors. It has seen substantial inorganic growth in the last five years. The acquisition of Health Net in 2016 bolstered the company’s growth, expansion as well as its asset base. Its solid financial position also provides a major boost to its capital deployment initiatives. The company’s strong Managed care segment also contributes to its strong results. The guidance raise for 2018 instills shareholders' confidence in the company. Centene has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the last 60 days. However, rising debt burden hurts the company's profitability. Moreover, increasing expenses also continue to weigh on the margins. The company will release first quarter 2018 results on Apr 24." (4/10/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Centene filed an 8-K which indicates that it will contribute $340 million (over five years) to New York State in conjunction with the Fidelis acquisition." (4/2/2018)
Who are some of Centene's key competitors?
Who are Centene's key executives?
Centene's management team includes the folowing people:
- Mr. Michael Frederic Neidorff, Chairman & CEO (Age 75)
- Ms. Cynthia J. Brinkley, Pres , COO, Chief Admin. & Markets Officer (Age 58)
- Mr. Jeffrey Alan Schwaneke CPA, CPA, Exec., CFO & Treasurer (Age 42)
- Mr. Keith Harvey Williamson, Exec. VP, Gen. Counsel & Corp. Sec. (Age 66)
- Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 42)
Has Centene been receiving favorable news coverage?
Media headlines about CNC stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Centene earned a daily sentiment score of 0.15 on Accern's scale. They also assigned news headlines about the company an impact score of 46.13 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are Centene's major shareholders?
Centene's stock is owned by many different of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.35%), Cortland Associates Inc. MO (0.16%), Assenagon Asset Management S.A. (0.13%), NN Investment Partners Holdings N.V. (0.08%), Nisa Investment Advisors LLC (0.06%) and Osborne Partners Capital Management LLC (0.06%). Company insiders that own Centene stock include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.
Which institutional investors are selling Centene stock?
CNC stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Retirement Systems of Alabama, Westpac Banking Corp, Bank of Montreal Can, Hartford Investment Management Co., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Osborne Partners Capital Management LLC and Hennessy Advisors Inc.. Company insiders that have sold Centene company stock in the last year include Christopher D Bowers, Jesse N Hunter, Keith H Williamson, Michael F Neidorff and Robert K Ditmore. View Insider Buying and Selling for Centene.
Which institutional investors are buying Centene stock?
CNC stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Palo Capital Inc., Cornerstone Wealth Management LLC, Boston Advisors LLC, Pendal Group Ltd, State of Alaska Department of Revenue, Gulf International Bank UK Ltd and Clinton Group Inc.. Company insiders that have bought Centene stock in the last two years include Robert K Ditmore and Stephen Wallace. View Insider Buying and Selling for Centene.
How do I buy shares of Centene?
Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene's stock price today?
One share of CNC stock can currently be purchased for approximately $135.45.
How big of a company is Centene?
Centene has a market capitalization of $27.79 billion and generates $48.38 billion in revenue each year. The company earns $828 million in net income (profit) each year or $5.03 on an earnings per share basis. Centene employs 33,700 workers across the globe.
How can I contact Centene?
Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]
MarketBeat Community Rating for Centene (NYSE CNC)
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
